Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.

<h4>Objective</h4>To assess the effects of subcutaneous (sc) interferon (IFN) -1a on cognition over 5 years in mildly disabled patients with relapsing-remitting multiple sclerosis (RRMS).<h4>Methods</h4>Patients aged 18-50 years with RRMS (Expanded Disability Status Scale sco...

Full description

Bibliographic Details
Main Authors: Francesco Patti, Vincenzo Brescia Morra, Maria Pia Amato, Maria Trojano, Stefano Bastianello, Maria Rosalia Tola, Salvatore Cottone, Andrea Plant, Orietta Picconi, COGIMUS Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24137499/pdf/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24137499/pdf/?tool=EBI

Similar Items